Translational Research & Psychiatry
The Department of Psychiatry and Behavioral Sciences is an emerging leader in psychiatric research. Faculty members are dedicated to exploring the psychological and neurobiological underpinnings of human behavior and mental disorders in addition to developing improved treatments and treatment-delivery systems using the most advanced research methods and technologies available.
Collaboration is pivotal to the department’s success, with translational teams of basic and clinical scientists working together to rapidly bring breakthroughs from the lab to the clinic. Mentorship is a departmental priority, as faculty members train the next generation of leaders in the field.
Areas of Research
Childhood Disorders & Developmental Neuroscience
The Center for Youth Mental Health — co-led by Steve Strakowski, M.D., and Deborah Cohen, Ph.D., LMSW — conducts research to support adolescents and young adults at risk for or in the early stages of severe mental illness. The center partners with community partners to design and test new models of mental health care and close gaps in treatment during the transition to adulthood.
IMProving Access to Collaborative Treatment (IMPACT) Autism Research Lab, directed by Jeffrey D. Shahidullah, Ph.D., is a family-centered research hub, joining clinical and academic programs to develop and disseminate equitable models to improve early detection and access to care for children with autism spectrum disorder and other neurodevelopmental disabilities.
The Interpersonal Impact of Trauma Lab, directed by Suzannah Creech, Ph.D., explores the intergenerational transmission of trauma from parents to children including developing and testing interventions to address the impact of parental experiences of trauma on children’s outcomes.
The Mood Addiction Interaction Neuroscience (MAIN) Lab, directed by Elizabeth Lippard, Ph.D., uses structural and functional brain imaging and behavioral techniques to examine the developmental mechanisms underlying the emergence of mood and substance use disorders during the transition from adolescence to early adulthood.
Women’s Reproductive Mental Health, directed by Jeff Newport, M.D., M.S., examines the earliest of childhood adversity, the potentially harmful effects of exposure to both maternal mental illness and maternal psychiatric medications during pregnancy and infancy.
The Institute for Early Life Adversity Research, directed by Charles B. Nemeroff, M.D., explores the mental health and medical consequences of childhood trauma as well as optimal treatments for trauma-related disorders using brain imaging, genomics and epigenetics, neuroendocrine and inflammatory markers to elucidate the mechanisms of resilience and vulnerability.
The Interpersonal Impact of Trauma Lab, directed by Suzannah Creech, Ph.D., seeks to understand the role of social and interpersonal relationships as mechanisms for improving functional and treatment outcomes in trauma-exposed populations, including an emphasis on prevention of interpersonal violence and its consequences.
The Mood Addiction Interaction Neuroscience (MAIN) Lab, directed by Elizabeth Lippard, Ph.D., uses neuroimaging to examine long-lasting neural consequences following early life stress, including childhood maltreatment and bullying victimization, and relations with development of mood and substance use disorders.
The Translational and Clinical Neuroscience (TrAC Neuro) Lab, directed by Greg Fonzo, Ph.D., seeks to understand the pathophysiological brain mechanisms and information-processing biases underlying affective disturbances in common trauma-related mental health conditions, such as post-traumatic stress disorder.
Women’s Reproductive Mental Health, directed by Jeff Newport, M.D., M.S., examines the enduring psychological and neurobiological impact of early trauma and their impact upon maternal behavior with a view to elucidating intergenerational effects of trauma.
Mark Bond, Ph.D. is developing new measurements of traumatic events that are specific to sexual and gender minority identities and is investigating the link between those adverse events and anxiety, depression and substance use.
The Healthcare Organization Science Lab, directed by Justin Benzer, Ph.D., studies the implementation of addiction treatment models with specific attention on the organizational opportunities and constraints for integrating treatment teams across the continuum of care.
The Mood Addiction Interaction Neuroscience (MAIN) Lab, directed by Elizabeth Lippard, Ph.D., conducts longitudinal studies using clinical/behavioral phenotyping, neuroimaging and genetic techniques to investigate initiation of substance use, emergence of substance misuse and development of addiction in typically developing youth and those with mood disorders.
Neuroimaging & Translational Neuroscience
The Bipolar Disorder Center, directed by Jorge Almeida, M.D., Ph.D., uses functional magnetic resonance imaging (fMRI) to investigate biomarkers of bipolar disorder, using standard neuroimaging data analysis along with effective connectivity and pattern recognition analysis.
The Institute for Early Life Adversity Research, directed by Charles B. Nemeroff, M.D., conducts functional and structural brain imaging studies to elucidate the neurobiological changes wrought by exposure to childhood traumatic experiences and the role these alterations play in the heightened vulnerability to subsequent illness.
The Learning, Memory, and Emotion Lab, directed by Joseph Dunsmoor, Ph.D., focuses on emotion and cognition interactions governing how we learn about and remember important events. Studies utilize Pavlovian conditioning, categorization, decision-making and episodic memory in conjunction with neuroimaging, psychophysiology and immersive virtual reality tools
The Mood Addiction Interaction Neuroscience (MAIN) Lab, directed by Elizabeth Lippard, Ph.D., conducts longitudinal structural and functional brain imaging studies in conjunction with behavioral techniques to elucidate the pathogenesis of mood and substance use disorders (and interactions between these conditions).
The Translational and Clinical Neuroscience (TrAC Neuro) Lab, directed by Greg Fonzo, Ph.D., conducts functional brain-imaging studies to elucidate both the effects of stress and the mechanisms by which psychiatric treatments promote a return to health with a view to designing novel precision medicine interventions informed by neural circuitry.
The Psychiatry Clinical Trials Program, directed by Sam Collier, M.D., collaborates with internal and external sponsors to execute high-quality investigations pertinent to various mental illnesses. This includes evaluation of novel pharmacologic compounds, implantable devices and psychotherapeutic interventions for treatment-resistant depression, mood and anxiety disorders, post-traumatic stress disorder and schizophrenia.
Women’s Reproductive Mental Health, directed by Jeff Newport, M.D., M.S., is a leader in examining the pharmacokinetic profiles and reproductive safety of psychiatric medications during pregnancy and lactation, including the physicochemical and genetic determinants of altered medication clearance during gestation, transplacental passage, breast milk excretion of medications.
Genetics, Genomics & Epigenetics
The Behavioral Immunology Lab, directed by Marisa Toups, M.D., uses functional genomic analysis to develop models of the immune response in mood disorders to understand increased vulnerability to infections, autoimmune and other chronic medical illness in mood disorders.
The Mood Addiction Interaction Neuroscience (MAIN) Lab, directed by Elizabeth Lippard, Ph.D., investigates genetic and familial influence on neural development and associations with the onset and disease course in mood disorders and substance use disorders.
Women’s Reproductive Mental Health, directed by Jeff Newport, M.D., M.S., examines the epigenetic and genomic effects of intrauterine exposure to both maternal psychiatric illness and maternal psychotropic medication and how these fetal exposures shape a child’s subsequent risk to illness.
The Behavioral Immunology Lab, directed by Marisa Toups, M.D., examines the relationship between immune activity, mood and behavior, with a focus on major depressive disorder. The ultimate goal is improving the efficacy of treatment for patients with co-occurring depression and medical illness.
The Bipolar Disorder Center, directed by Jorge Almeida, M.D., Ph.D., utilizes a multi-disciplinary approach to the treatment of bipolar disorder, conducting clinical trials of pharmacotherapies, psychotherapies and other interventions for those with bipolar disorder, including those with co-morbid disorders such as substance abuse.
The Healthcare Organization Science Lab, directed by Justin Benzer, Ph.D., conducts quantitative and qualitative studies to determine how organizational factors may impact access and quality of mental health care in the primary care setting, with a specific emphasis on depression care.
The Mood Addiction Interaction Neuroscience (MAIN) Lab, directed by Elizabeth Lippard, Ph.D., investigates risk (familial studies), onset and early illness course in bipolar disorder, with an emphasis on individual differences (e.g., neural and behavioral) that contribute to disease heterogeneity
Women’s Reproductive Mental Health, directed by Jeff Newport, M.D., M.S., studies the perinatal course of depressive and bipolar disorders, focusing on identifying predictors of vulnerability and resilience that will help inform clinical decision-making during pregnancy and lactation.
Health Services & Implementation Science
The Healthcare Organization Science Lab, directed by Justin Benzer, Ph.D., applies concepts from organizational psychology and health care management to identify and implement solutions to gaps in access and quality of mental health care.
The Interpersonal Impact of Trauma Lab, directed by Suzannah Creech, Ph.D., conducts basic and applied health services and implementation science research exploring the role of interpersonal and family factors in mental health treatment and illness trajectories after trauma, including a national dissemination of a trauma-informed treatment to address intimate partner violence.
Deborah Cohen, Ph.D., LMSW, examines system, program and practice barriers to effective mental health care delivery focused on improving access, engagement and outcomes for youth with emerging serious mental illnesses.